| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 8.733 | 20.951 | 37.525 | 27.636 | 28.982 | 27.659 | 22.777 | 25.485 |
| Total Income - EUR | - | - | 8.733 | 20.951 | 37.525 | 27.636 | 28.982 | 27.659 | 22.843 | 25.485 |
| Total Expenses - EUR | - | - | 10.063 | 17.731 | 36.354 | 25.745 | 28.034 | 27.256 | 21.120 | 23.793 |
| Gross Profit/Loss - EUR | - | - | -1.329 | 3.220 | 1.171 | 1.891 | 947 | 402 | 1.723 | 1.692 |
| Net Profit/Loss - EUR | - | - | -1.441 | 3.011 | 796 | 1.693 | 685 | 174 | 1.500 | 1.304 |
| Employees | - | - | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Epilsugar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 566 | 7.125 | 5.001 | 2.945 | 3.298 | 1.000 | 994 |
| Current Assets | - | - | 2.209 | 3.057 | 5.415 | 9.448 | 19.193 | 2.858 | 8.611 | 9.669 |
| Inventories | - | - | 1.329 | 994 | 3.319 | 3.304 | 3.869 | 1.850 | 6.774 | 7.915 |
| Receivables | - | - | 0 | 216 | 643 | 1.096 | 1.119 | 1 | 1.116 | 1.110 |
| Cash | - | - | 880 | 1.847 | 1.453 | 5.047 | 14.206 | 1.008 | 720 | 644 |
| Shareholders Funds | - | - | -1.398 | 1.639 | 2.403 | 4.050 | 4.645 | 4.834 | 4.626 | 5.905 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 3.606 | 1.984 | 10.137 | 10.399 | 17.493 | 4.486 | 4.985 | 4.758 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9622 - 9622" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Epilsugar S.r.l.